慢性肾脏病认知障碍机制新见解
New insights into mechanisms underlying cognitive impairment in chronic kidney disease.
PubMed 文献 · Kidney Int · 2024-01-01
慢性肾脏病(CKD)患者认知障碍风险增加,血脑屏障通透性增高。Zimmermann等发现小胶质细胞钾外流激活白细胞介素-1b/白细胞介素-1R通路,与CKD血脑屏障通透性和认知障碍相关,提示潜在治疗靶点。
要点
- CKD患者血脑屏障通透性增加,与认知障碍相关。
- 小胶质细胞钾外流激活IL-1b/IL-1R通路参与该过程。
- 该机制为CKD认知障碍提供潜在治疗靶点。
核心结论
- 小胶质细胞钾外流及IL-1b/IL-1R通路激活与CKD血脑屏障通透性和认知障碍相关。
主要发现
- CKD患者血脑屏障通透性增加。
- CKD中小胶质细胞钾外流增加并激活小胶质细胞。
- IL-1b/IL-1R通路激活与血脑屏障通透性和认知障碍相关。
临床怎么用
- 该机制提示IL-1b/IL-1R通路及小胶质细胞激活可能作为CKD认知障碍的干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) is associated with an increased risk of cognitive impairment. Patients with CKD display an increased permeability of the blood-brain barrier. Zimmermann et al. highlighted the implication of potassium efflux in the microglia and its activation, the activation of the interleukin-1b/interleukin-1R pathway, linked to blood-brain barrier permeability and cognitive impairment in CKD. Along with uremic toxicity, this study provides new solid insights about pathophysiological mechanisms of cognitive impairment in CKD, and potential therapeutic targets.
来源:Kidney Int,查看原文。版权归原作者所有。
引用
- Bobot M, Burtey S. New insights into mechanisms underlying cognitive impairment in chronic kidney disease. Kidney Int. 2024. PMID: 39577985. doi:10.1016/j.kint.2024.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。